Galapagos N.V. Sponsored ADR (LKFT) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.2x

Market Cap

$1.87B

MomentumView details →

1D Return

−1.83%

YTD Return

−12.78%

RSI (14)

49.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.2x

Market Cap

$1.87B

RSI (14)

49.9

MomentumView details →

1D Return

−1.83%

YTD Return

−12.78%

ProfitabilityView details →

Gross Margin

94.88%

Net Margin

60.23%

EBITDA Margin

54.67%

ROE (TTM)

18.34%

ROA (TTM)

17.81%

Asset Turnover

0.29x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+66.44%

EPS CAGR 3Y

+23.17%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.24

EPS Surprise

−61.88%

Beats (12Q)

1/12

Next Q EPS Est

−$0.95

Avg Surprise (4Q)

32.16%

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

32.82x

Quick Ratio

32.82x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

990.58M

Net Income (TTM)

596.63M

Op. CF (TTM)

−192.82M

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for LKFT.

Similar companies

Immunocore Holdings plcIMCR Damora Therapeutics, Inc.DMRA 金迪克688670.SH Mind Medicine (MindMed) Inc.MNMD Galapagos N.V.GLPG Braveheart Bio, Inc.BRVE Find similar companies →

Latest newsMore news →

No recent news for LKFT.